Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.

被引：0
|
作者：
Wimalasingham, Akhila Ganeshi
Lista, Alfonso Gomez de Liano
de Bruijn, Roderick
Haanen, John B. A. G.
Szabados, Bernadett
Hall, Peter
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TARGETED THERAPY IN FIRST-LINE THERAPY OF METASTATIC RENAL CELL CANCER (MRCC): SYSTEMATIC REVIEW WITH META-ANALYSIS (SRMA)
    Carcano, F. M.
    Santos, L. V.
    Tariki, M. S.
    Serrano, S. V.
    Sasse, A.
    Lima, J. P. S. N.
    ANNALS OF ONCOLOGY, 2010, 21 : 288 - 288
  • [22] The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer
    Sharpe, Kevin
    Stewart, Grant D.
    Mackay, Alan
    Van Neste, Christophe
    Rofe, Charlotte
    Berney, Dan
    Kayani, Irfan
    Bex, Axel
    Wan, Elaine
    O'Mahony, Fiach C.
    O'Donnell, Marie
    Chowdhury, Simon
    Doshi, Rukma
    Ho-Yen, Colan
    Gerlinger, Marco
    Baker, Dawn
    Smith, Neil
    Davies, Barry
    Sahdev, Anju
    Boleti, Ekaterini
    De Meyer, Tim
    Van Criekinge, Wim
    Beltran, Luis
    Lu, Yong-Jie
    Harrison, David J.
    Reynolds, Andrew R.
    Powles, Tom
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6924 - 6934
  • [23] Everolimus in patients with metastatic renal cell carcinoma refractory to VEGF-targeted therapy: REACT subgroup analysis of prior therapy.
    Larkin, James M. G.
    Blank, Christian U.
    Bono, Petri
    Gogov, Svetozar
    Panneerselvam, Ashok
    Garay, Carlos A.
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [24] TARGETED THERAPY FOR METASTATIC RENAL CELL CANCER
    Verbaeys, C.
    Hoebeke, P.
    Van Belle, S.
    Rottey, S.
    ACTA CLINICA BELGICA, 2010, 65 (02) : 115 - 121
  • [25] Is cytoreductive nephrectomy necessary for metastatic renal cell carcinoma: a systematic review and meta-analysis
    Luo, Xiaojin
    Yi, Meilian
    Hui, Qun
    Yin, Weihua
    Han, Dali
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7029 - 7037
  • [26] VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
    Fei Liu
    Xianguo Chen
    Ejun Peng
    Wei Guan
    Youyuan Li
    Zhiquan Hu
    Zhangqun Ye
    Qianyuan Zhuang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31 : 799 - 806
  • [27] VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
    Liu, Fei
    Chen, Xianguo
    Peng, Ejun
    Guan, Wei
    Li, Youyuan
    Hu, Zhiquan
    Ye, Zhangqun
    Zhuang, Qianyuan
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2011, 31 (06) : 799 - 806
  • [28] COMPARATIVE EFFECTIVENESS OF CYTOREDUCTIVE NEPHRECTOMY VERSUS TARGETED THERAPY IN THE INITIAL MANAGEMENT OF METASTATIC CLEAR CELL KIDNEY CANCER
    Macleod, Liam C.
    Odisho, Anobel Y.
    Holt, Sarah K.
    Tykodi, Scott S.
    Harper, Jonathan D.
    Gore, John L.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E966 - E967
  • [29] Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysis
    Lo, Shih-Jung
    Huang, Shu-Huan
    Lai, I-Li
    Chern, Yih-Jong
    Hsu, Yu-Jen
    Liao, Chun-Kai
    Cheng, Ching-Chung
    Tsai, Wen-Sy
    Hsieh, Pao-Shiu
    You, Jeng-Fu
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38 (01)
  • [30] Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysis
    Shih-Jung Lo
    Shu-Huan Huang
    I-Li Lai
    Yih-Jong Chern
    Yu-Jen Hsu
    Chun-Kai Liao
    Ching-Chung Cheng
    Wen-Sy Tsai
    Pao-Shiu Hsieh
    Jeng-Fu You
    International Journal of Colorectal Disease, 38
12345